PortfoliosLab logoPortfoliosLab logo
ISSC vs. OCUL
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

ISSC vs. OCUL - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Innovative Solutions and Support, Inc. (ISSC) and Ocular Therapeutix, Inc. (OCUL). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, ISSC achieves a -8.66% return, which is significantly higher than OCUL's -32.04% return. Over the past 10 years, ISSC has outperformed OCUL with an annualized return of 21.08%, while OCUL has yielded a comparatively lower 2.12% annualized return.


ISSC

1D
-4.63%
1M
-20.35%
YTD
-8.66%
6M
69.28%
1Y
47.99%
3Y*
36.38%
5Y*
23.39%
10Y*
21.08%

OCUL

1D
-6.25%
1M
-15.04%
YTD
-32.04%
6M
-34.42%
1Y
-2.48%
3Y*
2.59%
5Y*
-10.67%
10Y*
2.12%
*Multi-year figures are annualized to reflect compound growth (CAGR)

ISSC vs. OCUL - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
ISSC
Innovative Solutions and Support, Inc.
-8.66%121.78%0.12%3.77%25.32%0.61%29.83%158.41%-23.13%-11.71%
OCUL
Ocular Therapeutix, Inc.
-32.04%42.15%91.48%58.72%-59.68%-66.33%424.05%-0.75%-10.56%-46.83%

Correlation

The correlation between ISSC and OCUL is 0.15, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.15

Correlation (3Y)
Calculated over the trailing 3-year period

0.16

Correlation (5Y)
Calculated over the trailing 5-year period

0.16

Correlation (10Y)
Calculated over the trailing 10-year period

0.14

Correlation (All Time)
Calculated using the full available price history since Jul 28, 2014

0.14

Fundamentals

Market Cap

ISSC:

$316.63M

OCUL:

$1.85B

EPS

ISSC:

$0.94

OCUL:

-$1.45

PS Ratio

ISSC:

3.46

OCUL:

31.85

PB Ratio

ISSC:

4.39

OCUL:

3.18

Total Revenue (TTM)

ISSC:

$90.56M

OCUL:

$52.04M

Gross Profit (TTM)

ISSC:

$44.22M

OCUL:

$45.40M

EBITDA (TTM)

ISSC:

$26.70M

OCUL:

-$283.03M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

ISSC vs. OCUL — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ISSC
ISSC Risk / Return Rank: 6060
Overall Rank
ISSC Sharpe Ratio Rank: 6161
Sharpe Ratio Rank
ISSC Sortino Ratio Rank: 6262
Sortino Ratio Rank
ISSC Omega Ratio Rank: 6363
Omega Ratio Rank
ISSC Calmar Ratio Rank: 5959
Calmar Ratio Rank
ISSC Martin Ratio Rank: 5757
Martin Ratio Rank

OCUL
OCUL Risk / Return Rank: 4141
Overall Rank
OCUL Sharpe Ratio Rank: 4040
Sharpe Ratio Rank
OCUL Sortino Ratio Rank: 4242
Sortino Ratio Rank
OCUL Omega Ratio Rank: 4141
Omega Ratio Rank
OCUL Calmar Ratio Rank: 4040
Calmar Ratio Rank
OCUL Martin Ratio Rank: 4040
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ISSC vs. OCUL - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Innovative Solutions and Support, Inc. (ISSC) and Ocular Therapeutix, Inc. (OCUL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


ISSCOCULDifference
Sharpe ratioReturn per unit of total volatility

+0.62

Sortino ratioReturn per unit of downside risk

+0.85

Omega ratioGain probability vs. loss probability

1.18

1.06

+0.12

Calmar ratioReturn relative to maximum drawdown

0.83

-0.04

+0.88

Martin ratioReturn relative to average drawdown

1.55

-0.09

+1.63

ISSC vs. OCUL - Sharpe Ratio Comparison

The current ISSC Sharpe Ratio is 0.59, which is higher than the OCUL Sharpe Ratio of -0.04. The chart below compares the historical Sharpe Ratios of ISSC and OCUL, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


ISSCOCULDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.59

-0.04

+0.62

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.40

-0.14

+0.54

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.37

0.03

+0.34

Sharpe Ratio (All Time)

Calculated using the full available price history

0.12

-0.05

+0.17

Drawdowns

ISSC vs. OCUL - Drawdown Comparison

The maximum ISSC drawdown since its inception was -89.03%, smaller than the maximum OCUL drawdown of -95.19%. Use the drawdown chart below to compare losses from any high point for ISSC and OCUL.


Loading charts...

Drawdown Indicators


ISSCOCULDifference

Max Drawdown

Largest peak-to-trough decline

-89.03%

-95.19%

+6.16%

Max Drawdown (1Y)

Largest decline over 1 year

-57.83%

-57.29%

-0.54%

Max Drawdown (3Y)

Largest decline over 3 years

-57.83%

-72.67%

+14.84%

Max Drawdown (5Y)

Largest decline over 5 years

-57.83%

-86.17%

+28.34%

Max Drawdown (10Y)

Largest decline over 10 years

-62.41%

-90.94%

+28.53%

Current Drawdown

Current decline from peak

-43.39%

-80.93%

+37.54%

Average Drawdown

Average peak-to-trough decline

-50.60%

-76.62%

+26.02%

Ulcer Index

Depth and duration of drawdowns from previous peaks

31.10%

29.16%

+1.94%

Volatility

ISSC vs. OCUL - Volatility Comparison

Innovative Solutions and Support, Inc. (ISSC) has a higher volatility of 21.59% compared to Ocular Therapeutix, Inc. (OCUL) at 18.19%. This indicates that ISSC's price experiences larger fluctuations and is considered to be riskier than OCUL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


ISSCOCULDifference

Volatility (1M)

Calculated over the trailing 1-month period

21.59%

18.19%

+3.40%

Volatility (6M)

Calculated over the trailing 6-month period

64.39%

60.08%

+4.31%

Volatility (1Y)

Calculated over the trailing 1-year period

82.07%

69.77%

+12.30%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

58.74%

78.39%

-19.65%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

56.93%

78.80%

-21.87%

Dividends

ISSC vs. OCUL - Dividend Comparison

Neither ISSC nor OCUL has paid dividends to shareholders.


PositionTTM202520242023202220212020
ISSC
Innovative Solutions and Support, Inc.
0.00%0.00%0.00%0.00%0.01%0.00%17.64%
OCUL
Ocular Therapeutix, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Financials

ISSC vs. OCUL - Financials Comparison

This section allows you to compare key financial metrics between Innovative Solutions and Support, Inc. and Ocular Therapeutix, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


5.00M10.00M15.00M20.00M25.00M20222023202420252026
22.37M
10.79M
(ISSC) Total Revenue
(OCUL) Total Revenue
Values in USD except per share items

Frequently Asked Questions


ISSC and OCUL have a correlation of 0.15, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

ISSC has higher volatility (21.59%) compared to OCUL (18.19%). In terms of maximum drawdown, ISSC dropped -89.03% vs OCUL's -95.19%.

ISSC currently has the higher Sharpe Ratio (0.59 vs -0.04), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for ISSC and OCUL

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer